医学
心肌梗塞
重症监护医学
背景(考古学)
经皮冠状动脉介入治疗
肌钙蛋白
心理干预
生物标志物
心脏病学
内科学
古生物学
生物化学
化学
精神科
生物
作者
X. Huang,Suwen Bai,Yumei Luo
出处
期刊:Medicine
[Ovid Technologies (Wolters Kluwer)]
日期:2024-04-12
卷期号:103 (15): e37793-e37793
标识
DOI:10.1097/md.0000000000037793
摘要
Acute myocardial infarction (AMI), the most severe cardiovascular event in clinical settings, imposes a significant burden with its annual increase in morbidity and mortality rates. However, it is noteworthy that mortality due to AMI in developed countries has experienced a decline, largely attributable to the advancements in medical interventions such as percutaneous coronary intervention. This trend highlights the importance of accurate diagnosis and effective treatment to preserve the myocardium at risk and improve patient outcomes. Conventional biomarkers such as myoglobin, creatine kinase isoenzymes, and troponin have been instrumental in the diagnosis of AMI. However, recent years have witnessed the emergence of new biomarkers demonstrating the potential to further enhance the accuracy of AMI diagnosis. This literature review focuses on the recent advancements in biomarker research in the context of AMI diagnosis.
科研通智能强力驱动
Strongly Powered by AbleSci AI